Table 4 Levels of markers of inflammation, stress, and other hormones associated with breast cancer risk in breast cancer survivors over time (n = 10 per group)
| Â | Week 0 | Week 6 | Week 12 | Week 18 |
|---|---|---|---|---|
Leptin (ng/mL) | ||||
 CR | 47 (34.8, 59.3) | 21.5 (9.3, 33.8) | 19 (6.7, 31.2) | 26.2 (14, 38.5) |
 WM | 53.8 (41.5, 66) | 37.3 (25, 49.5) | 36.8 (24.5, 49) | 38.2 (26, 50.5) |
Adiponectin (μg/mL) | ||||
 CR | 12.8 (9.3, 16.2) | 9.6 (6.2, 13) | 11.1 (7.7, 14.5) | 13.8 (10.4, 17.2) |
 WM | 7.7 (4.3, 11.1) | 6.9 (3.5, 10.3) | 7.9 (4.5, 11.3) | 8.3 (4.9, 11.7) |
CRP (mg/L) | ||||
 CR | 6 (2.1, 9.8) | 4.3 (0.4, 8.1) | 3.2 (0, 7.1) | 3.8 (0, 7.7) |
 WM | 5.2 (1.3, 9) | 4.4 (0.6, 8.2) | 7.4 (3.6, 11.3) | 5.9 (2, 9.7) |
Interleukin-6 (pg/mL) | ||||
 CR | 2.7 (1.8, 3.6) | 2 (1.1, 2.9) | 2.2 (1.3, 3.1) | 2.4 (1.6, 3.3) |
 WM | 2.8 (1.9, 3.7) | 2.4 (1.5, 3.3) | 3.3 (2.4, 4.2) | 2.7 (1.8, 3.6) |
F2-isoprostanes (ng/mL) | ||||
 CR | 71.5 (52.5, 90.4) | – | 50 (31.1, 68.9) | 52.9 (33.9, 71.8) |
 WM | 81 (62, 100) | – | 62 (43.1, 81) | 64.9 (46, 83.9) |
Cortisol (ng/mL) | ||||
 CR | 26.4 (18.3, 34.6) | 21.2 (13.1, 29.4) | 27.1 (19, 35.3) | 23.1 (14.9, 31.3) |
 WM | 40.3 (32.1, 48.5) | 28.3 (20.1, 36.5) | 36.1 (27.9, 44.3) | 37 (28.8, 45.1) |
6-Sulfatoxymelatonin (ng/mg cr) | ||||
 CR | 8.1 (3, 13.3) | 8.6 (3.5, 13.8) | 5.8 (0.1, 11.6) | 10 (4.9, 15.2) |
 WM | 15.8 (10.7, 21) | 13.1 (7.7, 18.5) | 11.6 (6.4, 16.7) | 16.9 (11.8, 22.1) |